Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : CAR-T Cell Therapy
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Memorial Sloan Kettering Cancer Center
Deal Size : Undisclosed
Deal Type : Collaboration
Alaya.Bio Announces Collaboration with Top Global Cancer Center for In Situ CAR-T Therapy
Details : The collaboration will advance research into in situ CAR-T cell therapies and evaluate their potential to deliver faster, more effective, and cost-efficient treatments for patients.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 18, 2024
Lead Product(s) : CAR-T Cell Therapy
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Memorial Sloan Kettering Cancer Center
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?